gemcitabine has been researched along with Disease, Pulmonary in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alousi, AM; Anderlini, P; Champlin, RE; Fanale, MA; Hagemeister, FB; Hosing, CM; Khouri, IF; Ledesma, C; Neelapu, S; Nieto, Y; Oki, Y; Plair, T; Popat, UR; Romaguera, JE; Saliba, RM; Shpall, EJ; Younes, A | 1 |
| Boku, N; Endo, M; Igawa, S; Murakami, H; Nakamura, Y; Shukuya, T; Takahashi, T; Tamiya, A; Tsuya, A; Yamamoto, N | 1 |
| Bartlett, NL; Blum, KA; Byrd, JC; Cheson, BD; Hsi, ED; Johnson, JL; Jung, SH; Lin, TS; Lucas, DM | 1 |
| Arning, M; Cassidy, CA; Peterson, P; Roychowdhury, DF | 1 |
| Bosquée, L; D'Orio, V; Mommens, V | 1 |
| Camus, P | 1 |
| Bolt, K; Lammers, JW; Maas, KW; Schramel, FM; van der Lee, I; Zanen, P | 1 |
| Barlési, F; Doddoli, C; Gimenez, C; Kleisbauer, JP; Villani, P | 1 |
| Bredenfeld, H; Diehl, V; Engert, A; Franklin, J; Fries, S; Josting, A; Mailänder, V; Nogova, L; Oertel, J | 1 |
| Agelaki, S; Bozionelou, V; Georgoulias, V; Kakolyris, S; Kalbakis, K; Kouroussis, C; Malas, K; Mavroudis, D; Souglakos, J; Voloudaki, A | 1 |
| Fukuchi, Y; Ito, J; Kajiyama, Y; Miura, K; Miyamoto, H; Nagashima, O; Sato, K; Shimanuki, Y; Suzuki, T; Tajima, K; Takahashi, K; Uekusa, T | 1 |
| Buesa, JM; Capelan, M; Esteban, E; Estrada, E; Fernández, Y; Fra, J; Jiménez, P; Jiménez-Lacave, A; Llorente, B; Luque, M; Muñiz, I; Vieitez, JM; Villanueva, N | 1 |
| Marik, PE; Vahid, B | 1 |
| Bell, DR; Levi, JA; Millward, MJ; Pavlakis, N | 1 |
| Brand, R; Tempero, MA | 1 |
| Höffken, K; Kath, R; Sauer-Heilborn, A; Schneider, CP | 1 |
| Belle, E; Capellier, G; Caps, T; Carron, PL; Cousin, L; Neidhardt, A; Pernet, D | 1 |
3 review(s) available for gemcitabine and Disease, Pulmonary
| Article | Year |
|---|---|
[Asbestos--gemcitabin. Combined risk for pulmonary toxicity?].
Topics: Antimetabolites, Antineoplastic; Asbestos; Deoxycytidine; Gemcitabine; Humans; Incidence; Lung Diseases; Occupational Exposure; Risk Factors | 2003 |
Gemcitabine-induced severe pulmonary toxicity.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diagnosis, Differential; Disease Progression; Drug Interactions; Dyspnea; Gemcitabine; Humans; Lung; Lung Diseases; Lung Neoplasms; Radiography, Thoracic; Risk Factors | 2004 |
Pulmonary complications of novel antineoplastic agents for solid tumors.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bevacizumab; Deoxycytidine; Doxorubicin; Epirubicin; Etoposide; Everolimus; Gemcitabine; Humans; Lung; Lung Diseases; Mitoxantrone; Neoplasms; Pneumonia; Pyrimidines; Risk Factors; Sirolimus; Teniposide; Trastuzumab | 2008 |
3 trial(s) available for gemcitabine and Disease, Pulmonary
| Article | Year |
|---|---|
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Double-Blind Method; Doxorubicin; Female; Gemcitabine; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Neoplasm Staging; Polyethylene Glycols; Polymorphism, Single Nucleotide; Receptors, IgG; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine; Young Adult | 2010 |
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Gemcitabine; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 2004 |
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Diarrhea; Docetaxel; Female; Gemcitabine; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Taxoids; Time Factors; Treatment Outcome; Vinblastine; Vinorelbine | 2008 |
11 other study(ies) available for gemcitabine and Disease, Pulmonary
| Article | Year |
|---|---|
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Topics: Adult; Brentuximab Vedotin; Deoxycytidine; Female; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunoconjugates; Lung Diseases; Male; Melphalan; Middle Aged; Nausea; Remission Induction; Salvage Therapy; Skin Diseases; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2016 |
Features of gemcitabine-related severe pulmonary toxicity: patients with pancreatic or biliary tract cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Deoxycytidine; Female; Gemcitabine; Humans; Lung; Lung Diseases; Male; Middle Aged; Pancreatic Neoplasms; Pneumonia | 2009 |
A report on serious pulmonary toxicity associated with gemcitabine-based therapy.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Databases, Factual; Deoxycytidine; Female; Gemcitabine; Humans; Lung Diseases; Male; Middle Aged; Radiotherapy; Retrospective Studies; Risk Factors | 2002 |
[Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
Topics: Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Lung Diseases; Lung Neoplasms; Middle Aged; Ribonucleotide Reductases | 2003 |
Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/cisplatin as part of combined modality treatment.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Smoking | 2003 |
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Incidence; Lung Diseases; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Taxoids | 2004 |
[A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Radiography, Thoracic; Tomography, X-Ray Computed | 2006 |
Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Humans; Hypoxia; Lung Diseases; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Pulmonary Edema; Respiratory Distress Syndrome | 1997 |
Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Fatal Outcome; Gemcitabine; Humans; Infusions, Intravenous; Lung Diseases; Male | 1998 |
Severe non-haematological toxicity after treatment with gemcitabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Humans; Lung Diseases; Male; Middle Aged; Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Ventricular Dysfunction | 1999 |
Gemcitabine-associated diffuse alveolar hemorrhage.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Carcinoma, Large Cell; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemorrhage; Humans; Lung Diseases; Lung Neoplasms; Male; Pulmonary Alveoli; Steroids | 2001 |